Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Sales | 2,589 | 3,292 | 2,361 | 2,175 | 1,748 |
| Gross Profit | 2,589 | 3,292 | 2,361 | 2,175 | 1,748 |
| Operating Expenses | 15,929 | 13,753 | 13,189 | 13,211 | 12,190 |
| Operating Income | -13,340 | -10,461 | -10,828 | -11,036 | -10,442 |
| Other Income | 146 | 180 | 192 | 160 | 217 |
| Pre-tax Income | -13,194 | -10,281 | -10,636 | -10,876 | -10,225 |
| Net Income Continuous | -13,194 | -10,281 | -10,636 | -10,876 | -10,225 |
| Net Income | $-13,194 | $-10,281 | $-10,636 | $-10,876 | $-10,225 |
| EPS Basic Total Ops | -0.76 | -0.60 | -0.63 | -0.64 | -0.61 |
| EPS Basic Continuous Ops | -0.76 | -0.60 | -0.63 | -0.64 | -0.61 |
| EPS Diluted Total Ops | -0.76 | -0.60 | -0.63 | -0.64 | -0.61 |
| EPS Diluted Continuous Ops | -0.76 | -0.60 | -0.63 | -0.64 | -0.61 |
| EBITDA(a) | $-12,588 | $-9,574 | $-10,139 | $-10,482 | $-9,914 |